Press release
Hangzhou Thinheal Pharma-Tech Co., Ltd. to Showcase Peptide Innovation at FCE Pharma 2026 in Sao Paulo
As a key player in the global peptide API market, Thinheal brings over 20 years of combined industry expertise in peptide drug development, cGMP-compliant production, and customized CDMO services to the Latin American market. The company's participation in FCE Pharma 2026 underscores its commitment to expanding its footprint in the region and strengthening partnerships with pharmaceutical and biotech stakeholders across Brazil and beyond.
At Booth I155, attendees will have the opportunity to explore Thinheal's comprehensive portfolio of high-quality peptide products, including GLP-1 analogs, Therapeutic Peptides [https://www.thinhealpeptide.com/therapeutic-peptides/], and research-grade materials, all manufactured under strict quality control standards to meet international regulatory requirements. The Thinheal team will also be available to discuss tailored solutions for peptide drug development, from lab-scale synthesis to commercial-scale production, as well as ongoing collaborations and distribution opportunities in Latin America.
"FCE Pharma is a pivotal platform for connecting with the Latin American pharma community, and we are eager to share our latest advancements in peptide technology with regional partners," said a representative from Hangzhou Thinheal Pharma-Tech Co., Ltd. "We look forward to leveraging this event to foster new collaborations, address market needs, and support the growth of the Pharmaceutical Industry [https://www.thinhealpeptide.com/pharmaceutical-industry/] in Brazil and across Latin America."
The Sao Paulo Expo Exhibition & Convention Center is located at Rodovia dos Imigrantes, 1.5km - Jabaquara, Sao Paulo-SP. For those planning to attend FCE Pharma 2026, Thinheal invites you to visit Booth I155 to learn more about the company's products, capabilities, and partnership opportunities.
About Hangzhou Thinheal Pharma-Tech Co., Ltd.
Founded in 2019, Hangzhou Thinheal Pharma-Tech Co., Ltd. is a national high-tech enterprise dedicated to the research, development, production, and sales of peptide-based products. With a 2,000 sqm R&D center and multiple cGMP-compliant production lines, the company offers a full range of peptide industrialization services, including custom synthesis, API manufacturing, and CDMO solutions for clients worldwide. Thinheal's products are exported to markets across North America, Europe, Asia, and Latin America, supporting the development of innovative therapies and research initiatives globally.
Image: https://ecdn6-nc.globalso.com/upload/p/3990/image_other/2026-05/untitled-4.jpg
Media Contact
Company Name: Hangzhou ThinHeal Pharma-Tech Co., Ltd
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hangzhou-thinheal-pharmatech-co-ltd-to-showcase-peptide-innovation-at-fce-pharma-2026-in-so-paulo]
Country: China
Website: https://www.thinhealpeptide.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hangzhou Thinheal Pharma-Tech Co., Ltd. to Showcase Peptide Innovation at FCE Pharma 2026 in Sao Paulo here
News-ID: 4530559 • Views: …
More Releases from ABNewswire
Top 10 Tactical Uniforms for Global Buyers in 2026?
Looking ahead to 2026, it's pretty clear that the demand for quality Tactical Uniforms [https://www.sonicesafety.com/tactical-uniform/]is only going up among buyers worldwide. This shift really shows how people now more than ever recognize just how essential these uniforms are in a bunch of different jobs. Whether it's for military, police, or security teams, a well-made Tactical Uniform [https://www.sonicesafety.com/tactical-uniform/] can make a real difference-offering practicality and toughness you can count on.Big-name manufacturers…
Top Tips for Choosing the Right Safety Work Gloves?
Picking the right safety Work Glove [https://www.sonicesafety.com/work-glove/]s might seem like a small thing, but honestly, it's pretty important for any job site. The right pair can really make a difference - they protect your hands from getting hurt and also need to feel comfortable and not too stiff. With so many options out there, though, it can get kinda overwhelming trying to find the perfect match. That's why it's so…
Hot Rolled, Hot Dipped Galvanized & Galvalume Coils Empower Global Construction …
Advantages of core product
1. Cold Rolled SteelCoils
High tensile &wear resistance, high pressure resistance service for structural parts and heavy duty machine elements.
Good formability for bending, rolling and welding, withlittle cracks.
Efficient andcheap in the coiled form, eliminate wastes processing and financial burdens of logistics.
It iscommonly used in Steel Structure, pipe making, ship building, and engineering machine.
2. HotDipped Galvanized Coil& Hot Dipped Galvanized Steel Coils
Complete corrosion protection with dense tightly packed zinc…
Therabody Scales Ulta Beauty Partnership to Over 1,000 U.S. Stores
Image: https://ecdn6.globalso.com/upload/p/4060/image_other/2026-04/massage-gun-and-wellness-tools.jpg
Table of Contents
* Retail Expansion Overview
* Key Products Entering Stores
* Industry Impact
* Sources
Retail Expansion Overview
On March 31, 2026, Therabody announced a significant expansion of its partnership with Ulta Beauty, increasing its retail presence to over 1,000 stores nationwide. This move scales Therabody's U.S. distribution more than threefold compared to its initial 300-store rollout in the fall of 2025. The brand's percussive massagers and skincare tech will be prominently featured…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
